Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30142% above fair value
$55.37−0.01 (-0.02%)
Close on Nov 17, 2026Market cap $3.31BP/E –Yield –
Axogen total assets
Total assets on the balance sheet at the end of each period.
Axogen's total assets was $550.34M at Sep 30, 2026. For fiscal 2025 it was $221.69M, up 8.8% from the year before. Over ten years it grew 19.7% a year on average. The highest annual figure on record is $221.69M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $221.69M | +8.8% |
| FY2024 | Dec 31, 2024 | $203.73M | +3.5% |
| FY2023 | Dec 31, 2023 | $196.83M | +0.7% |
| FY2022 | Dec 31, 2022 | $195.39M | -6.1% |
| FY2021 | Dec 31, 2021 | $208.02M | +3.3% |
| FY2020 | Dec 31, 2020 | $201.38M | +30.2% |
| FY2019 | Dec 31, 2019 | $154.64M | -3.5% |
| FY2018 | Dec 31, 2018 | $160.17M | +172.1% |
| FY2017 | Dec 31, 2017 | $58.88M | +27.0% |
| FY2016 | Dec 31, 2016 | $46.36M | +26.3% |
| FY2015 | Dec 31, 2015 | $36.70M | +123.8% |
| FY2014 | Dec 31, 2014 | $16.40M | -40.8% |
| FY2013 | Dec 31, 2013 | $27.68M | +36.8% |
| FY2012 | Dec 31, 2012 | $20.23M | +61.9% |
| FY2011 | Dec 31, 2011 | $12.50M | +95.1% |
| FY2010 | Dec 31, 2010 | $6.41M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $550.34M | +154.3% |
| Q2 FY2026 | Jun 30, 2026 | $304.86M | +48.4% |
| Q1 FY2026 | Mar 31, 2026 | $289.49M | +47.6% |
| Q4 FY2025 | Dec 31, 2025 | $221.69M | +8.8% |
| Q3 FY2025 | Sep 30, 2025 | $216.40M | +12.7% |
| Q2 FY2025 | Jun 30, 2025 | $205.45M | +8.7% |
| Q1 FY2025 | Mar 31, 2025 | $196.17M | +5.2% |
| Q4 FY2024 | Dec 31, 2024 | $203.73M | +3.5% |
| Q3 FY2024 | Sep 30, 2024 | $191.99M | -1.4% |
| Q2 FY2024 | Jun 30, 2024 | $188.93M | -1.4% |
| Q1 FY2024 | Mar 31, 2024 | $186.52M | -1.6% |
| Q4 FY2023 | Dec 31, 2023 | $196.83M | +0.7% |
| Q3 FY2023 | Sep 30, 2023 | $194.63M | -0.5% |
| Q2 FY2023 | Jun 30, 2023 | $191.64M | -2.3% |
| Q1 FY2023 | Mar 31, 2023 | $189.47M | -4.3% |
| Q4 FY2022 | Dec 31, 2022 | $195.39M | -6.1% |
| Q3 FY2022 | Sep 30, 2022 | $195.52M | -6.9% |
| Q2 FY2022 | Jun 30, 2022 | $196.08M | -6.9% |
| Q1 FY2022 | Mar 31, 2022 | $198.03M | +0.3% |
| Q4 FY2021 | Dec 31, 2021 | $208.02M | +3.3% |
| Q3 FY2021 | Sep 30, 2021 | $209.97M | +8.3% |
| Q2 FY2021 | Jun 30, 2021 | $210.53M | +23.9% |
| Q1 FY2021 | Mar 31, 2021 | $197.37M | +36.2% |
| Q4 FY2020 | Dec 31, 2020 | $201.38M | +30.2% |
| Q3 FY2020 | Sep 30, 2020 | $193.94M | +25.8% |
| Q2 FY2020 | Jun 30, 2020 | $169.96M | +8.5% |
| Q1 FY2020 | Mar 31, 2020 | $144.88M | -9.7% |
| Q4 FY2019 | Dec 31, 2019 | $154.64M | -3.5% |
| Q3 FY2019 | Sep 30, 2019 | $154.19M | -4.6% |
| Q2 FY2019 | Jun 30, 2019 | $156.60M | -2.5% |
| Q1 FY2019 | Mar 31, 2019 | $160.49M | +190.9% |
| Q4 FY2018 | Dec 31, 2018 | $160.17M | +172.1% |
| Q3 FY2018 | Sep 30, 2018 | $161.66M | +282.8% |
| Q2 FY2018 | Jun 30, 2018 | $160.54M | +275.4% |
| Q1 FY2018 | Mar 31, 2018 | $55.17M | +27.5% |
| Q4 FY2017 | Dec 31, 2017 | $58.88M | +27.0% |
| Q3 FY2017 | Sep 30, 2017 | $42.23M | – |
| Q2 FY2017 | Jun 30, 2017 | $42.77M | – |
| Q1 FY2017 | Mar 31, 2017 | $43.27M | – |
| Q4 FY2016 | Dec 31, 2016 | $46.36M | – |
See a number that looks wrong?